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We recently published data on self-monitoring of blood glucose (SMBG) behaviour 
among non-insulin treated patients with type 2 diabetes mellitus in Tayside, Scotland, and 
their behavioural responses to SMBG readings
1
. We now present additional data relating 
to the perceptions of high readings of 207 patients (58% male; mean age 63 years; range 
36-76 years). They all had electronic records of SMBG prescriptions dispensed and were 
a representative sample recruited from primary care
1
. Diabetes duration ranged from <2 
years (8%) to >10 years (29%).   80% were treated with metformin and/or 
sulphonylureas, 10% with injections of exenatide or liraglutide, and 12% by diet/lifestyle.  
Patients were asked to indicate what blood glucose readings that they ‘were happy with’, 
and those that they ‘considered to be high’. For specified values, we calculated the 
proportion that would be ‘happy with’ these readings (Fig 1), with the majority being 
‘happy with’ readings between 5 and 7mmol/l. Notably, though, 35% were ‘happy with’ 
8mmol/l, and 17% with 9mmol/l.  Although these values were not related to specific 
times of the day, only 11 (5%) patients reported that they checked their blood glucose 
levels after meals (when higher values are acceptable). When patients were asked what 
they considered to be a ‘high’ reading, some gave very specific ranges (e.g. ‘12.9 to 13’; 
‘10.5-11.1’) while others were more general (e.g. ‘anything above 10’; ‘double-digits’). 
Fig 1 shows the proportions of patients who considered specified values (or over) to be 
high. Where a range was given, we determined the lowest value of this range. For 68% of 
patients, this was 10mmol/l. For 10%, it was 16mmol/l. Interestingly, 128 of the patients 
reported having received information/education on SMBG, 112 of whom stated that they 
had been told what their targets should be.   
Although these findings may help to explain the lack of empirical evidence surrounding 
the clinical benefits of monitoring (ie; the failure of many studies to identify an 
association between SMBG and improved glycaemic control may be because many 
patients are satisfied with high blood glucose readings and do not respond to readings 
recognized clinically to be high), they do need to be interpreted with caution. While many 
patients may not have knowledge of appropriate target ranges, it may also be that some 
use SMBG principally to avoid hypoglycaemia (around half of our patients were treated 
with sulphonylureas). Clinicians therefore need to understand the particular reasons and 
motivations of patients who self-monitor when they discuss target ranges, and also be 
aware that there may be upward slippage in patients’ targets over time (as observed 
among patients with type 1 diabetes for a variety of reasons
2
). If patients do wish to 
continue SMBG, they need to have education on appropriate blood glucose level targets 
for their particular context, and this may need to be re-inforced over time.  
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1. Fig 1: Proportions of patients who would be ‘happy with’ readings of a specified 
level (mmol/l) (upper panel), and proportions who considered readings of a 
specified level (mmol/l) to be ‘high’ (lower panel) 
 
 
 
 
 
  
